Geron Corp/ US3741631036 /
| 2024-05-08 9:55:37 PM | Chg. -0.0650 | Volume | Bid2024-05-08 | Ask2024-05-08 | High | Low |
|---|---|---|---|---|---|---|
| 3.8050USD | -1.68% | 3.58 mill. Turnover: 12.24 mill. |
3.8000Bid Size: 15,600 | 3.8100Ask Size: 6,700 | 3.9000 | 3.7750 |
GlobeNewswire
04-30
Aqua Security and Orca Security Partner to Address Joint Customer Need for Best-in-Class Cloud Nativ...
GlobeNewswire
03-05
Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expande...
GlobeNewswire
03-05
Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expande...
GlobeNewswire
2021-10-20
The MDS Foundation Celebrates MDS World Awareness Day With Their 4th Annual Move for MDS 5k Walk at ...
GlobeNewswire
2021-08-02
Arch Oncology Strengthens Medical and Clinical Leadership Teams with Key Appointments
GlobeNewswire
2021-04-27
SHAREHOLDER ALERT: Barr Law Group Investigating GERN, MIE, CG, and EVF; Shareholders are Encouraged ...
GlobeNewswire
2021-04-21
Ponzi Scheme Investigation: 1inMM Capital, LLC Investors Who Have Suffered Investment Losses Encoura...
GlobeNewswire
2021-04-20
GERON CORPORATION INVESTOR ALERT: Geron Investors Who Have Held Their Stock Continuously Since At Le...
GlobeNewswire
2021-04-18
Lifshitz Law Firm, P.C. Announces Investigations of Geron Corp. (NasdaqGS: GERN), Jeld-Wen Holding, ...
GlobeNewswire
2021-03-31
AC Immune Appoints Experienced Biotech and Investment Executive Dr. Alan Colowick to Board of Direct...
GlobeNewswire
2021-03-24
Harpoon Therapeutics Appoints Experienced Biotech Leader Alan Colowick, M.D., to Board of Directors
GlobeNewswire
2020-11-05
Geron Corporation Reports Third Quarter 2020 Financial Results and Current Events
GlobeNewswire
2020-08-04
Biopharmaceutical Leader Robert J. Spiegel, MD, FACP Appointed to the Athenex Board of Directors
GlobeNewswire
2020-07-01
Geron Receives Positive Opinion from the EMA Committee for Orphan Medicinal Products for Orphan Drug...
GlobeNewswire
2020-06-12
Geron Reports Four Imetelstat Data Presentations at Virtual Edition of the European Hematology Assoc...
GlobeNewswire
2020-05-27
Geron Corporation Announces the Closing of its Public Offering of Common Stock and Warrants
GlobeNewswire
2020-05-22
Geron Corporation Announces the Pricing of its Public Offering of Common Stock and Warrants
GlobeNewswire
2020-05-21
Geron Corporation Announces Proposed Public Offering of Common Stock and Warrants
GlobeNewswire
2020-05-21
Geron Announces Plans for Imetelstat Phase 3 Clinical Trial in Myelofibrosis and Other Updates
